Viewing Study NCT07142551


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:30 PM
Study NCT ID: NCT07142551
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-08-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module